GR3005036T3 - - Google Patents

Info

Publication number
GR3005036T3
GR3005036T3 GR920400491T GR920400491T GR3005036T3 GR 3005036 T3 GR3005036 T3 GR 3005036T3 GR 920400491 T GR920400491 T GR 920400491T GR 920400491 T GR920400491 T GR 920400491T GR 3005036 T3 GR3005036 T3 GR 3005036T3
Authority
GR
Greece
Prior art keywords
adsorption
elution
onto
plasma
subsequent
Prior art date
Application number
GR920400491T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005036T3 publication Critical patent/GR3005036T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR920400491T 1989-05-05 1992-06-26 GR3005036T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3914869A DE3914869C1 (el) 1989-05-05 1989-05-05

Publications (1)

Publication Number Publication Date
GR3005036T3 true GR3005036T3 (el) 1993-05-24

Family

ID=6380171

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920400491T GR3005036T3 (el) 1989-05-05 1992-06-26

Country Status (8)

Country Link
US (1) US5061789A (el)
EP (1) EP0396022B1 (el)
JP (1) JP2593951B2 (el)
AT (1) ATE76751T1 (el)
DE (2) DE3914869C1 (el)
DK (1) DK0396022T3 (el)
ES (1) ES2037499T3 (el)
GR (1) GR3005036T3 (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT402261B (de) * 1991-01-25 1997-03-25 Immuno Ag Komplex enthaltend den gerinnungsfaktor ix
AT395597B (de) * 1991-01-25 1993-01-25 Immuno Ag Reagens zur bestimmung von faktor viii-aktivitaet
DK0573605T3 (da) * 1991-03-01 2001-01-02 Rhone Poulenc Rorer Int Fremstilling af faktor IX
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
DE4342132C1 (de) * 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
DE19504852C2 (de) * 1995-02-15 2003-01-23 Octapharma Ag Lachen Verfahren zur Reinigung Vitamin K-abhängiger Gerinnungsfaktoren durch Affinitäts-Chromatographie
US5714583A (en) * 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
DE10045434B4 (de) * 2000-09-14 2005-07-14 Fresenius Hemocare Gmbh Adsorbens mit unterschiedlich modifizierten Oberflächenbereichen, Verfahren zu dessen Herstellung und Verwendung davon
US9488625B2 (en) 2010-12-15 2016-11-08 Baxalta GmbH Purification of factor VIII using a conductivity gradient
US9663553B2 (en) 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma
CA3078625C (en) 2017-10-09 2023-01-17 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same
WO2020185916A1 (en) 2019-03-14 2020-09-17 Terumo Bct Biotechnologies, Llc Lyophilization container fill fixture, system and method of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
DE3172210D1 (en) * 1980-05-27 1985-10-17 Miles Lab Blood coagulation promoting product and process of preparing same
DE3033932C2 (de) * 1980-09-10 1984-05-24 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Kaltsterilisation von Blutgerinnungsfaktor VIII enthaltenden Präparaten
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"
US4447416A (en) * 1982-04-28 1984-05-08 American National Red Cross Plasma protein concentrates of reduced thrombogenicity and their use in clinical replacement therapy
US4721572A (en) * 1985-07-12 1988-01-26 Miles Laboratories, Inc. Purfication of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices
US4725673A (en) * 1986-08-29 1988-02-16 Alpha Therapeutic Corporation Plasma fraction purification using silica resin bound to a ligand
DE3877529T2 (de) * 1987-10-23 1996-11-07 Centre Regional De Transfusion Herstellung von hoch-gereingtem menschlichen Faktor IX sowie anderem Plasmaproteinkonzentrat und dessen therapeutische Verwendung.
DE3826792C1 (el) * 1988-08-06 1989-07-06 Biotest Pharma Gmbh, 6072 Dreieich, De

Also Published As

Publication number Publication date
DE59000141D1 (de) 1992-07-09
DE3914869C1 (el) 1990-08-09
JPH02306994A (ja) 1990-12-20
JP2593951B2 (ja) 1997-03-26
US5061789A (en) 1991-10-29
DK0396022T3 (da) 1992-07-20
EP0396022A1 (de) 1990-11-07
ATE76751T1 (de) 1992-06-15
EP0396022B1 (de) 1992-06-03
ES2037499T3 (es) 1993-06-16

Similar Documents

Publication Publication Date Title
GR3005036T3 (el)
AU580402B2 (en) Method of inactivating viruses involving adsorption on solid phase
GR3003819T3 (el)
ES2051970T3 (es) Procedimiento para la preparacion de un concentrado de trombina muy puro.
EP0330047A3 (en) Method for the sterilization of blood, blood derivatives, plasma derivatives, cell suspensions or the like
DE3379644D1 (en) Adsorbent and process for preparing the same
HK45193A (en) Ozone decontamination of blood and blood products
ES2121915T3 (es) Ligandos del receptor eck.
FI77048B (fi) Foerfarande foer framstaellning av en blodkoagulationsbefraemjande preparation pao basis av humanproteiner.
NO954815D0 (no) Fremgangsmåte for sterilisering av biologiske blandinger og produkter fremstilt med denne
ES502497A0 (es) Procedimiento de obtencion de preparados promotores de la coagulacion sanguinea
SE8009157L (sv) Sett att framstellning hogrenade koncentrat av protrombinkomplex, de erhallna koncentraten och framstellning derav
GB1527268A (en) Antiserum for the quantitative determination of the decomposition products x and y of fibrin and fibrinogen
ES8407499A1 (es) Un metodo para la obtencion de interferon inmune humano homogeneo de pureza aumentada.
DE58907555D1 (de) Verfahren zur Anreicherung der Blutgerinnungsfaktoren II, VII, IX und X.
DK241684D0 (da) Fremgangsmaade til fremstilling af et antithrombin iii-heparin-eller antithrombin iii-heparinoidkoncentrat
Riesz et al. Free-Radical Distribution in the γ-Radiolysis of Dry Ribonuclease1
SE8801426D0 (sv) Forfarande och medel for blodbehandling
BR9608147A (pt) Método para descontaminação microbiana de plaquetas sanguìneas.
EP0331327A3 (en) Agent for blocking nonspecific adsorption, process for preparing thereof and method of blocking nonspecific adsorption
Shuster et al. Inactivation of choline acetyltransferases by an antiserum to the enzyme from mouse brain
Kaye et al. Rose bengal immobilized on sepharose—a new tool for protein photo-oxidation
MY113294A (en) A process for the preparation of a virus inactivated fraction containing factor viii by means of chromatographic methods
Bartosz et al. Irradiation increases proteolysis in erythrocyte ghosts: a spin label study
GB906860A (en) Improvements relating to blood coagulation test reagents